Ivermaxx 40 mg

When 40 mg matches the calculated dose for an ivermectin-sensitive infection, treatment can:

• Reduce susceptible parasite populations

• Support clearance of certain intestinal infections

• Control symptoms caused by parasite activity

• Help manage selected parasite-related skin conditions

• Reduce complications associated with untreated infection

• Provide the calculated dose in one fixed-strength tablet

Treatment success depends on identifying the correct parasite and following the selected schedule. Strongyloidiasis can require follow-up stool examinations, while onchocerciasis can require later assessment or retreatment.

Research into COVID-19 and cancer contributes to scientific understanding of ivermectin. It has not confirmed clinical benefits from Ivermaxx 40 mg for either condition.

Ivermectin attaches to glutamate-gated chloride channels in the nerve and muscle cells of susceptible parasites. This increases chloride movement into the cells and disrupts their normal electrical activity.

The affected parasites become paralysed and die or are gradually removed from the body. Ivermectin does not work against every parasite or every stage of a parasite’s life cycle. It also does not treat bacterial or fungal infections.

Researchers studying COVID-19 and cancer have examined ivermectin’s effects on cellular signalling, inflammation and immune activity. Effects seen in laboratory experiments cannot confirm that the same results will occur safely in patients.

Ivermaxx 40 mg dosage is determined by body weight, the diagnosed parasite, medical history and the required treatment schedule. The complete 40 mg tablet should only be used when it matches the calculated amount.

For strongyloidiasis, prescribing references commonly use approximately 200 micrograms of ivermectin per kilogram of body weight as a single oral dose. For onchocerciasis, approximately 150 micrograms per kilogram is commonly used. These figures provide medical context and are not instructions for calculating a personal dose.

Take the prescribed amount with water. Many oral ivermectin labels recommend taking it on an empty stomach. Follow-up tests or another dose at a defined interval are included in some treatment plans.

If the calculated dose is lower than 40 mg, an appropriate tablet strength or combination should be selected. Do not estimate the required amount, round the dose upward or divide the tablet unless clear instructions confirm that splitting is suitable.

There is no established Ivermaxx 40 mg dosage for COVID-19 or cancer, as the clinical trials are still ongoing. Research protocols use carefully selected doses and monitoring and should never be copied for self-treatment.

Common Side Effects: Ivermaxx 40 mg can cause nausea, diarrhoea, stomach discomfort, reduced appetite, dizziness, headache, weakness, itching or a mild rash. Fever, muscle or joint discomfort, swollen lymph nodes and temporary worsening of skin symptoms can occur as the body reacts to dying parasites. Contact a healthcare professional if these effects continue or become difficult to manage.

Serious Side Effects: Seek immediate medical attention for breathing difficulty, facial or throat swelling, a severe or blistering rash, fainting, seizures, confusion, difficulty walking, extreme drowsiness, major vision changes or yellowing of the skin or eyes. A heavy Loa loa infection can increase the risk of serious neurological reactions after ivermectin treatment.

Ivermaxx 40 mg requires medical assessment for:

• People allergic to ivermectin

• Children weighing below 15 kg

• Pregnant or breastfeeding women

• People with significant liver problems

• People at risk of Loa loa infection

• People taking warfarin

• People using strong sedatives

• People receiving chemotherapy or immunotherapy

• People considering COVID-19 self-treatment

• People considering cancer self-treatment

Tell the healthcare professional about every medicine, supplement and herbal product being used.

Important interactions requiring review include:

• Warfarin and other anticoagulants

• Sedatives and sleeping medicines

• Certain antifungal medicines

• Macrolide antibiotics

• HIV protease inhibitors

• Anti-seizure medicines

• Other ivermectin products

• Chemotherapy and immunotherapy

Warfarin users can require additional blood-clotting tests. Taking more than one ivermectin product can also result in an unintended total dose.

• Keep the tablets in their original strip.

• Follow the storage temperature printed on the pack.

• Store in a cool and dry place.

• Protect from heat, moisture and sunlight.

• Keep away from children and pets.

• Do not use damaged or discoloured tablets.

• Check the batch number and expiry date.

• Dispose of expired tablets according to local guidance.